Calidi Biotherapeutics raises $1.2M via registered direct offering
Calidi Biotherapeutics sold 1,025,640 common shares at $1.17 per share, generating about $1.2 million in gross proceeds. The offering closed September 21, 2026.
Calidi Biotherapeutics entered into a Stock Purchase Agreement to raise capital through a registered direct offering. 2 million in gross proceeds. The offering closed on September 21, 2026, with no und…